ReLIA Biotech
Latest round
- Series C
Last raised
- May 2018
Total raised
- Undisclosed
Investors
- 2
About ReLIA Biotech
, Ltd. is a medical company that provides rapid diagnostic service and two rapid detection systems, including multi-functional immunoassay system and immunofluorescence detection system. The company has a foundational R&D center in Silicon Valley, California, USA and R&D centers and production bases in Shenzhen and Taizhou. With a team exceeding 200 members and a R&D team of over 50 professionals, RELIA's leadership includes founder Dr. Willian J Rutter, a renowned entrepreneur in precision medicine with experience at Novartis and Abbott. The company also holds over 20 patents and more than 50 product certifications. The company offers a range of bedside rapid testing systems, including a multifunctional immunoassay system and an immunofluorescence rapid testing system. Their testing projects cover rapid detection series for cardiovascular diseases, acute kidney injury, and rapid detection of inflammation and infectious diseases. The company generates revenue by providing POCT devices and testing reagents.
Who invested in ReLIA Biotech
2 investors across 1 round
See all investors in ReLIA Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
May 1, 2018
Amount
Undisclosed
Investors
Questions about ReLIA Biotech
Who invested in ReLIA Biotech?
ReLIA Biotech has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ReLIA Biotech raised?
ReLIA Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ReLIA Biotech last raise money?
ReLIA Biotech's most recent round on record is a Series C, in May 2018.
What does ReLIA Biotech do?
ReLIA Biotech is a medical devices & equipment company.
Where is ReLIA Biotech headquartered?
ReLIA Biotech is headquartered in Shenzhen, China.
Which VCs invest in companies like ReLIA Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at ReLIA Biotech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like ReLIA Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.